抗结核药物手册。引言。 - Suppr

Suppr

超能文献

Handbook of anti-tuberculosis agents. Introduction.

出版信息

Tuberculosis (Edinb). 2008 Mar;88(2):85-6. doi: 10.1016/S1472-9792(08)70002-7.

DOI:10.1016/S1472-9792(08)70002-7

PMID:18486036

Abstract

摘要

相似文献

Handbook of anti-tuberculosis agents. Introduction.

Tuberculosis (Edinb). 2008 Mar;88(2):85-6. doi: 10.1016/S1472-9792(08)70002-7.

[Publications on chemotherapy of pulmonary tuberculosis 1989-1990].

Probl Tuberk. 1991(10):87-9.

[Problems in organizing intensive, short-term antituberculosis chemotherapy in a national program].

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1988 Jan-Mar;37(1):5-13.

[Symposium on comparison of clinical efficacy of various kinds of chemotherapeutic regimens for pulmonary tuberculosis. Introduction. Clinical and comparative experimental studies in tuberculosis].

Kekkaku. 1966 Sep;41(9):430-1.

The study of the determinants of non adherence to anti-tuberculosis treatment: are we using appropriate research methodology?

Int J Tuberc Lung Dis. 1999 Nov;3(11):1049.

Initial drug resistance pattern in new cases of pulmonary tuberculosis.

J Assoc Physicians India. 2008 Mar;56:202.

[The current status of drug therapy of tuberculosis].

Ned Tijdschr Geneeskd. 1966 Jan 29;110(5):247-51.

[Anti-tuberculosis treatment evaluation in northern districts of Buenos Aires suburbs].

Medicina (B Aires). 2008;68(2):185-6.

[Studies on 11-OH corticosteroids level in blood serum in relation to the administration of the anti-inflammatory and anti-allergic drug "sodium oxyferriscarbone"].

Gruzlica. 1968 Oct;36(10):977-8.

[Use of aerosol therapy with antitubercular medicines in patients with pulmonary tuberculosis in a mental hospital].

Vopr Kurortol Fizioter Lech Fiz Kult. 2007 Sep-Oct(5):44-5.

引用本文的文献

Proteomic characterization of subjected to carbon starvation.

mSystems. 2025 May 20;10(5):e0153024. doi: 10.1128/msystems.01530-24. Epub 2025 Apr 15.

Microbiota alterations in patients treated for susceptible or drug-resistant TB.

IJTLD Open. 2024 Aug 1;1(8):355-361. doi: 10.5588/ijtldopen.24.0325. eCollection 2024 Aug.

First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drug.

J Antimicrob Chemother. 2024 Jun 3;79(6):1353-1361. doi: 10.1093/jac/dkae107.

Review on the Applications of Selected Metal-Based Complexes on Infectious Diseases.

Molecules. 2024 Jan 14;29(2):406. doi: 10.3390/molecules29020406.

Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro Characterization.

Pharmaceutics. 2023 Sep 20;15(9):2354. doi: 10.3390/pharmaceutics15092354.

High-Speed Tableting of High Drug-Loaded Tablets Prepared from Fluid-Bed Granulated Isoniazid.

Pharmaceutics. 2023 Apr 13;15(4):1236. doi: 10.3390/pharmaceutics15041236.

Latent Tuberculosis: A Promising New Compound to Treat Non-Replicating and Intramacrophagic Mycobacteria.

Biomedicines. 2022 Sep 26;10(10):2398. doi: 10.3390/biomedicines10102398.

The pursuit of mechanism of action: uncovering drug complexity in TB drug discovery.

RSC Chem Biol. 2021 Apr 1;2(2):423-440. doi: 10.1039/d0cb00226g. Epub 2021 Jan 13.

Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis.

Antimicrob Agents Chemother. 2020 Sep 21;64(10). doi: 10.1128/AAC.01174-20.

Identification of Anti-tuberculosis Compounds From Aurone Analogs.

Front Microbiol. 2020 May 20;11:1004. doi: 10.3389/fmicb.2020.01004. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Handbook of anti-tuberculosis agents. Introduction.

出版信息

Tuberculosis (Edinb). 2008 Mar;88(2):85-6. doi: 10.1016/S1472-9792(08)70002-7.

DOI:10.1016/S1472-9792(08)70002-7

PMID:18486036

Abstract

摘要

相似文献

Handbook of anti-tuberculosis agents. Introduction.

Tuberculosis (Edinb). 2008 Mar;88(2):85-6. doi: 10.1016/S1472-9792(08)70002-7.

[Publications on chemotherapy of pulmonary tuberculosis 1989-1990].

Probl Tuberk. 1991(10):87-9.

[Problems in organizing intensive, short-term antituberculosis chemotherapy in a national program].

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1988 Jan-Mar;37(1):5-13.

[Symposium on comparison of clinical efficacy of various kinds of chemotherapeutic regimens for pulmonary tuberculosis. Introduction. Clinical and comparative experimental studies in tuberculosis].

Kekkaku. 1966 Sep;41(9):430-1.

The study of the determinants of non adherence to anti-tuberculosis treatment: are we using appropriate research methodology?

Int J Tuberc Lung Dis. 1999 Nov;3(11):1049.

Initial drug resistance pattern in new cases of pulmonary tuberculosis.

J Assoc Physicians India. 2008 Mar;56:202.

[The current status of drug therapy of tuberculosis].

Ned Tijdschr Geneeskd. 1966 Jan 29;110(5):247-51.

[Anti-tuberculosis treatment evaluation in northern districts of Buenos Aires suburbs].

Medicina (B Aires). 2008;68(2):185-6.

[Studies on 11-OH corticosteroids level in blood serum in relation to the administration of the anti-inflammatory and anti-allergic drug "sodium oxyferriscarbone"].

Gruzlica. 1968 Oct;36(10):977-8.

[Use of aerosol therapy with antitubercular medicines in patients with pulmonary tuberculosis in a mental hospital].

Vopr Kurortol Fizioter Lech Fiz Kult. 2007 Sep-Oct(5):44-5.

引用本文的文献

Proteomic characterization of subjected to carbon starvation.

mSystems. 2025 May 20;10(5):e0153024. doi: 10.1128/msystems.01530-24. Epub 2025 Apr 15.

Microbiota alterations in patients treated for susceptible or drug-resistant TB.

IJTLD Open. 2024 Aug 1;1(8):355-361. doi: 10.5588/ijtldopen.24.0325. eCollection 2024 Aug.

First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drug.

J Antimicrob Chemother. 2024 Jun 3;79(6):1353-1361. doi: 10.1093/jac/dkae107.

Review on the Applications of Selected Metal-Based Complexes on Infectious Diseases.

Molecules. 2024 Jan 14;29(2):406. doi: 10.3390/molecules29020406.

Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro Characterization.

Pharmaceutics. 2023 Sep 20;15(9):2354. doi: 10.3390/pharmaceutics15092354.

High-Speed Tableting of High Drug-Loaded Tablets Prepared from Fluid-Bed Granulated Isoniazid.

Pharmaceutics. 2023 Apr 13;15(4):1236. doi: 10.3390/pharmaceutics15041236.

Latent Tuberculosis: A Promising New Compound to Treat Non-Replicating and Intramacrophagic Mycobacteria.

Biomedicines. 2022 Sep 26;10(10):2398. doi: 10.3390/biomedicines10102398.

The pursuit of mechanism of action: uncovering drug complexity in TB drug discovery.

RSC Chem Biol. 2021 Apr 1;2(2):423-440. doi: 10.1039/d0cb00226g. Epub 2021 Jan 13.

Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis.

Antimicrob Agents Chemother. 2020 Sep 21;64(10). doi: 10.1128/AAC.01174-20.

Identification of Anti-tuberculosis Compounds From Aurone Analogs.

Front Microbiol. 2020 May 20;11:1004. doi: 10.3389/fmicb.2020.01004. eCollection 2020.